NRF2 as an emerging therapeutic target

Ian M. Copple; Albena T. Dinkova-Kostova; Thomas W. Kensler; Karen T. Liby; W. Christian Wigley

doi:10.1155/2017/8165458

NRF2 as an emerging therapeutic target

Ian M. Copple (Lead / Corresponding author)
, Albena T. Dinkova-Kostova
, Thomas W. Kensler
, Karen T. Liby
, W. Christian Wigley

Research output: Contribution to journal › Editorial › peer-review

40 Citations (Scopus)

289 Downloads (Pure)

Original language	English
Article number	8165458
Pages (from-to)	1-2
Number of pages	2
Journal	Oxidative Medicine and Cellular Longevity
Volume	2017
DOIs	https://doi.org/10.1155/2017/8165458
Publication status	Published - 31 Jan 2017

Access to Document

10.1155/2017/8165458Licence: CC BY

Final Published Version
Copyright © 2017 Ian M. Copple et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Final published version, 1.15 MBLicence: CC BY

Cite this

@article{240183fe5a2340898b3da042d04e4790,

title = "NRF2 as an emerging therapeutic target",

author = "Copple, \{Ian M.\} and Dinkova-Kostova, \{Albena T.\} and Kensler, \{Thomas W.\} and Liby, \{Karen T.\} and Wigley, \{W. Christian\}",

year = "2017",

month = jan,

day = "31",

doi = "10.1155/2017/8165458",

language = "English",

volume = "2017",

pages = "1--2",

journal = "Oxidative Medicine and Cellular Longevity",

issn = "1942-0900",

publisher = "Wiley",

}

TY - JOUR

T1 - NRF2 as an emerging therapeutic target

AU - Copple, Ian M.

AU - Dinkova-Kostova, Albena T.

AU - Kensler, Thomas W.

AU - Liby, Karen T.

AU - Wigley, W. Christian

PY - 2017/1/31

Y1 - 2017/1/31

UR - https://www.scopus.com/pages/publications/85013407884

U2 - 10.1155/2017/8165458

DO - 10.1155/2017/8165458

M3 - Editorial

C2 - 28250892

SN - 1942-0900

VL - 2017

SP - 1

EP - 2

JO - Oxidative Medicine and Cellular Longevity

JF - Oxidative Medicine and Cellular Longevity

M1 - 8165458

ER -

NRF2 as an emerging therapeutic target

Access to Document

Other files and links

Cite this